349 related articles for article (PubMed ID: 11844733)
41. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
42. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
[TBL] [Abstract][Full Text] [Related]
43. TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
Papadopoulos K; Tozer DJ; Fisniku L; Altmann DR; Davies G; Rashid W; Thompson AJ; Miller DH; Chard DT
Mult Scler; 2010 Apr; 16(4):427-33. PubMed ID: 20086026
[TBL] [Abstract][Full Text] [Related]
44. A semiautomated measure of whole-brain atrophy in multiple sclerosis.
Bermel RA; Sharma J; Tjoa CW; Puli SR; Bakshi R
J Neurol Sci; 2003 Apr; 208(1-2):57-65. PubMed ID: 12639726
[TBL] [Abstract][Full Text] [Related]
45. Resting state networks change in clinically isolated syndrome.
Roosendaal SD; Schoonheim MM; Hulst HE; Sanz-Arigita EJ; Smith SM; Geurts JJ; Barkhof F
Brain; 2010 Jun; 133(Pt 6):1612-21. PubMed ID: 20356855
[TBL] [Abstract][Full Text] [Related]
46. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
47. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
[TBL] [Abstract][Full Text] [Related]
48. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.
De Stefano N; Matthews PM; Filippi M; Agosta F; De Luca M; Bartolozzi ML; Guidi L; Ghezzi A; Montanari E; Cifelli A; Federico A; Smith SM
Neurology; 2003 Apr; 60(7):1157-62. PubMed ID: 12682324
[TBL] [Abstract][Full Text] [Related]
49. Grey matter atrophy in patients with benign multiple sclerosis.
Niiranen M; Koikkalainen J; Lötjönen J; Selander T; Cajanus A; Hartikainen P; Simula S; Vanninen R; Remes AM
Brain Behav; 2022 Jul; 12(7):e2679. PubMed ID: 35765699
[TBL] [Abstract][Full Text] [Related]
50. Quantitative susceptibility mapping of both ring and non-ring white matter lesions in relapsing remitting multiple sclerosis.
Coffman CH; White R; Subramanian K; Buch S; Bernitsas E; Haacke EM
Magn Reson Imaging; 2022 Sep; 91():45-51. PubMed ID: 35605736
[TBL] [Abstract][Full Text] [Related]
51. Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study.
Rashid W; Davies GR; Chard DT; Griffin CM; Altmann DR; Thompson AJ; Miller DH
Mult Scler; 2007 Mar; 13(2):178-85. PubMed ID: 17439882
[TBL] [Abstract][Full Text] [Related]
52. White matter T(1) relaxation time histograms and cerebral atrophy in multiple sclerosis.
Vaithianathar L; Tench CR; Morgan PS; Lin X; Blumhardt LD
J Neurol Sci; 2002 May; 197(1-2):45-50. PubMed ID: 11997065
[TBL] [Abstract][Full Text] [Related]
53. Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years.
Turner B; Lin X; Calmon G; Roberts N; Blumhardt LD
Mult Scler; 2003 Feb; 9(1):21-7. PubMed ID: 12617263
[TBL] [Abstract][Full Text] [Related]
54. Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis.
Bieniek M; Altmann DR; Davies GR; Ingle GT; Rashid W; Sastre-Garriga J; Thompson AJ; Miller DH
J Neurol Neurosurg Psychiatry; 2006 Sep; 77(9):1036-9. PubMed ID: 16793860
[TBL] [Abstract][Full Text] [Related]
55. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis.
Griffin CM; Chard DT; Parker GJ; Barker GJ; Thompson AJ; Miller DH
J Neurol; 2002 Feb; 249(2):193-9. PubMed ID: 11985386
[TBL] [Abstract][Full Text] [Related]
56. Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up study.
Dolezal O; Gabelic T; Horakova D; Bergsland N; Dwyer MG; Seidl Z; Krasensky J; Ramasamy DP; Vaneckova M; Havrdova E; Zivadinov R
Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S42-8. PubMed ID: 24321154
[TBL] [Abstract][Full Text] [Related]
57. Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
Fisher E; Nakamura K; Lee JC; You X; Sperling B; Rudick RA
Mult Scler; 2016 Apr; 22(5):668-76. PubMed ID: 26238463
[TBL] [Abstract][Full Text] [Related]
58. Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.
Megna R; Alfano B; Lanzillo R; Costabile T; Comerci M; Vacca G; Carotenuto A; Moccia M; Servillo G; Prinster A; Brescia Morra V; Quarantelli M
J Neurol; 2019 Feb; 266(2):361-368. PubMed ID: 30498912
[TBL] [Abstract][Full Text] [Related]
59. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
[TBL] [Abstract][Full Text] [Related]
60. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]